Catch up on the top radiology content of the past week.
|Articles|January 28, 2004
Cardiovascular boom appears on horizon
The use of CT angiography will increase rapidly over the next five years, complementing or replacing other cardiovascular examinations, such as diagnostic cardiac catheterization, MR, and nuclear imaging, according to ECRI. The nonprofit health services
Advertisement
The use of CT angiography will increase rapidly over the next five years, complementing or replacing other cardiovascular examinations, such as diagnostic cardiac catheterization, MR, and nuclear imaging, according to ECRI. The nonprofit health services research group expects the number of diagnostic cardiac catheterization procedures to decrease over the next few years, particularly for assessing plaque, stenoses, and myocardial viability and for ruling out atherosclerosis. Driving this trend will be the increased installation of dedicated CT scanners into high-volume cardiology departments. More advanced CT technology, such as the 32- and 40-slice scanners recently introduced at the 2003 RSNA meeting, may dramatically increase the range of cardiac imaging applications that can be performed. Details are included in ECRI's Health Technology Forecast, a strategic technology planning resource for healthcare executives.
Advertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
3
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
4
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
5